ALTER-UC-001: Phase II trial of anlotinib plus everolimus as first-line treatment for advanced non-clear cell renal cell carcinoma.
Anlotinib;Everolimus
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: ALTER-UC-001: Phase II trial of anlotinib plus everolimus as first-line treatment for advanced non-clear cell renal cell carcinoma. ### Output: Anlotinib;Everolimus